ACC	adrenocortical carcinoma
Adr	adriamycin
ApoG2	apogossypolone
AUC	area under the curve
Bax	Bcl-2-associated X protein
Bcl-2	B-cell lymphoma 2
Bcl-xL	B-cell lymphoma-extra-large
Bim	Bcl-2-like protein 11
BNIP3	BCL2 interacting protein 3
CAD	caspase-activated deoxyribonuclease
CDK	cyclin-dependent kinase 4
CHOP	cyclophosphamide-adriamycin-vincristine-prednisolone
DR5	death receptor 5
DT	doubling time
ER	Endoplasmic reticulum
EGFR	epidermal growth factor receptor
GADD45α	growth arrest and DNA damage-inducible 45α
HCC	hepatocellular carcinoma
HNSCC	head and neck squamous cell carcinoma
ICAD	inhibitor of CAD
IL	interleukin
i.v.	intravenous
JNK	Jun N-terminal kinase
Mcl-1	myeloid cell leukemia 1
MM	multiple myeloma
NSCLC	non-small cell lung cancer
NO	nitric oxide
PARP	poly (ADP-ribose) polymerase
PCNA	Proliferating cell nuclear antigen
p-Rb	phospho-retinoblastoma
PRISMA	Preferred Reporting Items for Systematic Reviews and Meta-Analysis
PUMA	p53 upregulated modulator of apoptosis
RCT	randomized controlled trial
ROS	reactive oxygen species
TGF-1	transforming growth factor 1